Navigation Links
Sitagliptin in Medical News

Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009

... (6:30 PM ET). Poster Late Breaker: "DURATION-2: Exenatide Once Weekly Demonstrated Superior Glycemic Control and Weight Reduction Compared to sitagliptin or Pioglitazone after 26 Weeks of Treatment" will be presented by Richard Bergenstal, M.D., during a poster session on Saturday, June 6 from 11:30 AM ...

Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes

...m HCl (Welchol(R)), Rosiglitazone (Avandia(R)), or sitagliptin (Januvia (R) ) in Patients with Type 2 Diabete...ol 3.75 g/d (n=57), rosiglitazone 4 mg/d (n=56) or sitagliptin 100 mg/d (n=56). This study was designed to evalu...1C between the groups. Welchol, rosiglitazone and sitagliptin each significantly reduced mean A1C (p<0.05, &l...

Popular diabetes treatment could trigger pancreatitis, pancreatic cancer

...in humans. Januvia is marketed by Merck & Co. Inc. sitagliptin is a member of a new class of drugs that enhance t...used human IAPP transgenic (HIP) rats to test both sitagliptin and metformin; metformin, a member of an older, di...ced insulin sensitivity in the test rats. With the sitagliptin alone, however, the rats had abnormally high rates...

New Study Data: JANUVIA&#8482; (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes

...controlled factorial study of initial therapy with sitagliptin in combination with metformin, the incidence of hy...ients given placebo, 0.6 percent in patients given sitagliptin alone, 0.8 percent in patients given metformin alone and 1.6 percent in patients given sitagliptin in combination with metformin. Dosing of JAN...

Cost of Diabetes Care Has Doubled

...ssue of the Archives of Internal Medicine . The dramatic increase in cost is due to the high cost of commonly prescribed newer drugs. For example, sitagliptin (Januvia) costs $160 per prescription and exenatide (Byetta) costs $210 per prescription. That's eight to 11 times higher than older, generic drugs su...

Two-in-one Diabetic Drug Approved by FDA

...investigational oral medicine combining Januvia or sitagliptin phosphate, with the older widely-used generic drug...min (at least 1,500 mg daily). In this study, sitagliptin phosphate 100 mg once daily added to patients inad...lso observed that the concurrent administration of sitagliptin phosphate with metformin was generally well tolera...

Sitagliptin, Under Investigation For Type 2 Diabetes

...d and not when blood glucose is low). If approved, sitagliptin would be a member of a new class of antihyperglyca...e similar to placebo. In addition, patients taking sitagliptin experienced no significant weight gain and a low r...ight into the efficacy and tolerability profile of sitagliptin over a longer period of time. ...
Sitagliptin in Medical Technology

Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study

SAN DIEGO, INDIANAPOLIS and CAMBRIDGE, Mass., March 31 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly and Company (NYSE: LLY ) and Alkermes, Inc. (Nasdaq: ALKS ) today announced positive results from DURATION-2, the second in a series of studies designed to...

Research: Popular Diabetes Medications Associated with Increase in Bone Fractures

...dict Pancreatitis Risk from Incretin Mimetics New research suggests that the medications known as incretin mimetics -- which include exenatide and sitagliptin -- do not increase the risk of pancreatitis in patients with diabetes, contradicting previous case reports concerning the drug class that led to stron...

DURABLE Clinical Trial Results Show GlycoMark is Key Test for Managing Patients with Diabetes

...ramlintide-Treated Subjects Reference: American Association of Clinical Endocrinologists 2007 Annual Meeting (Cameron Lush) Efficacy and Safety of sitagliptin Monotherapy in Japanese Patients with Type 2 Diabetes Reference: Diabetes Research and Clinical Practice 2008 (Kenji Noaka) Does serum 1,5-AG esta...

Metabolex Initiates Phase 1 Trial of MBX-2982

...owever, MBX-2982 can be delivered orally. In addition, MBX-2982 may provide additional benefit when used in combination with a DPP-4 inhibitor such as sitagliptin (Januvia(R)), or other oral therapies. "We have identified a number of potent GPR119 agonists that improve glucose control in normal and diabetic an...

FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008

...ion from the enzyme is very slow. Such kinetics confer potency and long activity. During OGTT in normal mice, ARI- 2243 was 250 times more potent than sitagliptin and maximally lowered blood glucose by 88%. Additionally, in ZDF rats, an animal model that develops overt diabetes, ARI-2243 significantly reduced he...

Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes

.... There are no contraindications for JANUVIA. sitagliptin is also a component of JANUMET(TM) (sitagliptin/me... who are not adequately controlled on metformin or sitagliptin alone or in patients already being treated with th... important and useful information about the use of sitagliptin and metformin, in addition to diet and exercise, i...

An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes

...ngs. There are no contraindications for JANUVIA. sitagliptin is also a component of JANUMET(TM) (sitagliptin/me... who are not adequately controlled on metformin or sitagliptin alone or in patients already being treated with th...therapy and for those not adequately controlled on sitagliptin is 50 mg...
Other Tags
(Date:3/3/2015)... 2015 Introducing 3D Digital Technologies ... a recognized leader in Digital Dentistry. Acute precision ... best dental replicas, leaving no room for error ... dental professionals are able to significantly reduce “chair ... deliver remarkable quality while reducing labor and material ...
(Date:3/3/2015)... Splashtop Inc. , the worldwide ... now available for Epson® MoverioTM BT-200 smart glasses. ... Apps Market , iPod, iPhone, and iPad users can ... Epson Moverio smart glasses using Mirroring360, enhancing the user ... The Epson smart glasses have an advanced binocular optical ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Retrofit ... epidemic at America’s leading corporations, today announces the appointment ... senior executive positions. CEO Mary Pigatti has ... innovation and employee engagement for the fast-growing company, which ... to watch for 2015. , “Retrofit is thrilled ...
(Date:3/3/2015)... March 03, 2015 March 3, 2015, My ... 200th episode. The episode was a unique one, not just ... but because it featured two men who were both faced ... At the beginning of the episode, Deierlein said to Collins, ... my radio show, but I’m very excited that you could ...
(Date:3/3/2015)... Hyderabad, India (PRWEB) March 03, 2015 ... conference, speaker and continuing medical education (CME) credit ... comprehensive database for doctors was initially launched in ... the first of its kind in the field ... The second launch of this Denver, Colorado-based start-up ...
Breaking Medicine News(10 mins):Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 2Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 3Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 2Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 3Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 2Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 3Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 4Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2Health News:eMedEvents Launches Online Medical Conference, Speaker and CME Platform in India 2
(Date:2/23/2015)... OXFORD, Conn. , Feb. 23, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... it has filed provisional patent 62114357 for ... With this patent, NXT-ID introduces a new groundbreaking payment ... and the payment account may only be accessed if ...
(Date:2/13/2015)... , Feb. 13, 2015 ACT Genomics ... that aims to transform cancer genomic information into ... the company has raised US$ 8 million in the ... in Taipei, Taiwan , ACT ... ACTOnco™. With the aim to implement next generation ...
(Date:2/11/2015)... 2015 According to ... Market by Product (Cards and Readers, Biometrics, Controllers, Management ... Industrial, Healthcare, Education) and By Geography - Global Forecast and Analysis ... Access Control Market is expected to reach ... CAGR of 10.6% between 2014 and 2020. ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3ACT Genomics Raises $8 Million in its First Private Funding Round 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
Other Contents